17 June 2003 12:07
Isonics Corporation Sponsors International Conference on Silicon-28
/Science Writers
GOLDEN, Colo.--(BUSINESS WIRE)--June 17, 2003--Isonics Corporation (NASDAQ:ISON), a leader in the development of
isotopically engineered semiconductor materials, a supplier of silicon-on-insulator (SOI) wafers, and isotopes for life
sciences and health care applications, announced that for the second year it is sponsoring the Conference on "High
Purity Mono-isotopic Silicon Production, Analysis, Properties, and Applications," to be held June 19 through 22 in
Nizhny Novgorod, Russia.
The conference is organized by a scientific committee consisting of internationally known scientists and researchers
from Russia, Germany, Japan, and Belgium. Over 100 attendees are expected at the Conference, which will be hosted by the
Institute of Chemistry of High-Purity Substances of the Russian Academy of Sciences, a well-known and respected
high-purity materials research facility.
Over 30 papers are expected to be presented on topics including new methods and improvements of enriching silicon
isotopes; the economics of silicon isotope production; production of single crystals of silicon-28; the unique
properties obtained through isotopic purification; and new potential applications. Isonics supports the Conference in
its efforts to further the use of enriched silicon in semiconductor applications. Isonics currently has a number of
commercial evaluation programs in various stages of testing of silicon-28 wafers for a wide range of applications in the
semiconductor industry and has a Cooperative Research & Development Agreement (CRADA) with Lawrence Berkeley
National Laboratory to investigate the properties of silicon isotopes.
--30--AS/cg* CONTACT: Isonics Corporation Boris Rubizhevsky, 201/279-7900 www.isonics.com or Investor Awareness, Inc.
Tony Schor/Paul Arndt, 847/945-2222 www.investorawareness.com
About Isonics Corporation
Isonics is a world leader in isotopically engineered materials and produces isotopically pure silicon-28 chemicals
and wafers and silicon-on-insulator wafers (SOI) for the semiconductor industry. Isonics also markets and sells stable
isotopes for the health care industry such as Oxygen-18 for positron emission tomography (PET) imaging. The company is
also a leading supplier of several radioactive isotopes used in medical imaging and therapy. Isotopes can be thought of
as ultra pure materials. For additional information visit www.isonics.com.
Except for historical information contained herein, this document contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and
uncertainties that may cause the Company's actual results or outcomes to be materially different from those
anticipated and discussed herein, and which may result in the parties being unable or unwilling to complete the
transaction described herein. Further, the Company operates in industries where securities values may be volatile and
may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the
Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB
for the year ended April 30, 2002 as filed with the Securities and Exchange Commission, which include the Company's
cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In
assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements
contained in the Company's filings with the Securities and Exchange Commission.
[CAIW [Corporate Announcements Intelligence Wire]] |
RUSSIA IN FACTS
